Publikationen in Zusammenarbeit mit Forschern von Vall d'Hebron Institut de Recerca (12)

2024

  1. Detection of Alpha-1 Antitrypsin Levels in Chronic Obstructive Pulmonary Disease in Respiratory Clinics in Spain: Results of the EPOCONSUL 2021 Audit

    Journal of Clinical Medicine, Vol. 13, Núm. 4

2023

  1. Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study

    Biomedicines, Vol. 11, Núm. 2

  2. Smoking and COPD Knowledge in the General Spanish Population: A CONOCEPOC Study

    Journal of Clinical Medicine, Vol. 12, Núm. 13

2022

  1. Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update

    Archivos de Bronconeumologia, Vol. 58, Núm. 4, pp. 345-351

  2. Spanish COPD Guidelines (GesEPOC) 2021 Update Diagnosis and Treatment of COPD Exacerbation Syndrome

    Archivos de Bronconeumologia, Vol. 58, Núm. 2, pp. 159-170

  3. Spanish COPD Guidelines (GesEPOC) 2021: Updated Pharmacological treatment of stable COPD

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 69-81

  4. [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care

    Archivos de Bronconeumologia, Vol. 58, Núm. 4, pp. T334-T344

2021

  1. GesEPOC 2021: One More Step Towards Personalized Treatment of COPD

    Archivos de Bronconeumologia

  2. Results of a Diagnostic Procedure Based on Multiplex Technology on Dried Blood Spots and Buccal Swabs for Subjects With Suspected Alpha1 Antitrypsin Deficiency

    Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 42-50

  3. Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care

    Archivos de Bronconeumologia

  4. Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update

    Archivos de Bronconeumologia

2018

  1. Evaluating the impact of morning symptoms in COPD using the capacity of daily living during the morning (CDLM) questionnaire

    International Journal of COPD, Vol. 13, pp. 3837-3844